TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
ADXN
Addex Therapeutics
$
()
ADXN
Addex Therapeutics regains compliance with Nasdaq
ADXN
2/9/2023 - 05:16am
Addex Therapeutics completes enrollment in part one of ADX71149 trial
ADXN
,
JNJ
2/6/2023 - 05:15am
Addex Therapeutics extends term of collaboration agreement with Indivior
ADXN
12/8/2022 - 05:25am
Addex Therapeutics receives noncompliance notification
ADXN
11/3/2022 - 05:31am
Addex Therapeutics files to sell 4.25M American Depositary Shares for holders
ADXN
8/19/2022 - 16:58pm
Addex Therapeutics, Indivior extend GABAB PAM collaboration agreement
ADXN
,
INVVY
8/15/2022 - 05:20am
Addex Therapeutics raises $4.2M in equity financing
ADXN
7/22/2022 - 07:12am
Addex Therapeutics reduces nominal value of shares
ADXN
7/21/2022 - 05:30am
Addex Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
ADXN
6/23/2022 - 06:34am
Fly Intel: Pre-market Movers
CNC
,
ROKU
,
REV
…
6/17/2022 - 08:52am
Addex Therapeutics terminates dipraglurant study, suspends guidance
ADXN
6/17/2022 - 05:09am
Addex Therapeutics price target lowered to $15 from $21 at H.C. Wainwright
ADXN
5/31/2022 - 06:16am
Addex reports feasibility study of dipraglurant did not meet all objectives
ADXN
5/27/2022 - 05:10am
Addex Therapeutics completes patient enrollment in dipraglurant study
ADXN
4/13/2022 - 05:14am
Addex Therapeutics moves M4 muscarinic receptor PAM into lead optimization
ADXN
4/6/2022 - 05:16am
dynamic_feed
Breaking News
search
Search
menu
Menu